Belvedere Trading
RDHL

Belvedere Trading’s Redhill Biopharma RDHL Stock Holding History

Belvedere Trading’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10
Closed -$1.33K – 1346
2022
Q4 		$1.33K Buy
+10
New +$4.33K ﹤0.01% 1059
2021
Q4 		– Sell
-1
Closed -$4K – 591
2021
Q3 		$4K Buy
+1
New +$6.78K ﹤0.01% 466

Other funds holding RDHL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Belvedere Trading's RDHL Position: Q1 2023 in Review

Belvedere Trading sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 10 shares — an estimated $1.33K sold.

Belvedere Trading first reported a position in RDHL in Q3 2021 and held it in 2 quarters. The position peaked at $4K in Q3 2021. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Belvedere Trading reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Belvedere Trading sold 10 Redhill Biopharma shares in Q1 2023, an estimated $1.33K.
  • Belvedere Trading first reported a position in Redhill Biopharma in Q3 2021 and held it in 2 quarters.
  • Belvedere Trading's Redhill Biopharma position peaked at $4K in Q3 2021.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.